Integra LifeSciences released the Integra Freedom Wrist Arthroplasty System in the United States.
The system, which is used in the treatment of wrist arthritis, has been successfully implanted in 21 patients, over the summer. The system aims at aiding efficient and potentially more reproducible surgical results.
"The Integra Freedom Wrist Arthroplasty System complements and expands our upper extremity portfolio and offers our surgeons an advanced anatomic solution for wrist arthroplasty procedures. We believe this product is a natural addition to our portfolio and will add to our success and growth in this market," said Mark Augusti, corporate vice president and president, Integra Orthopedics and Tissue Technologies.
More articles on devices:
Global biomaterials market to reach $33.6B in 2019: 5 observations
10 big spine, orthopedic device company acquisitions in 2014
Pacira Pharmaceuticals' "hyper growth" leads to "Buy" rating reiterated